Drawing for N

USPTO serial 97231248

N

Status 641Office Action
Filing date
Jan 21, 2022
Status date
Jul 27, 2026
Registration date
Examiner
KUNKLEMAN, SARAH E

Need help with N?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: 27 Oct 2026

Office Action issues

The trademark examiner has temporarily paused the review of your application and requires you to have a U.S.-licensed attorney represent you because your business is located outside of the United States.

Owner

  • New Gene (Hangzhou) Bioengineering Co., Ltd.

    Hangzhou, Zhejiang,, CN

Goods and services

ClassDescriptionStatusFirst use
005Disinfectants; Biological tissue cultures for medical purposes; Diagnostic preparations for medical purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Injectable dermal fillers; Mixed biological preparations for the prevention and treatment of infectious diseases; Opium alkaloid preparations; Prescription synthetic narcotics; Reagent paper for medical purposesACTIVEDec 1, 2021

Prosecution history

DateCodeEvent
Aug 27, 2026DOCKASSIGNED TO EXAMINER
Jul 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 27, 2026GNRTNON-FINAL ACTION E-MAILED
Jul 27, 2026CNRTNON-FINAL ACTION WRITTEN
Jul 20, 2026DOCKASSIGNED TO EXAMINER
Jul 7, 2023WOAGWITHDRAWAL OF ATTORNEY GRANTED
Jul 7, 2023WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jan 27, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2022NWAPNEW APPLICATION ENTERED

Related guidance